Barclays PLC P Lx Pharma Inc. Transaction History

Barclays PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$7.69 - $19.66 $56,829 - $145,287	-7,390 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$12.22 - $21.28 $81,446 - $141,831	6,665 Added 919.31%	7,390 $143,000
Q2 2021 Aug 13, 2021	BUY	$9.0 - $15.94 $6,156 - $10,902	684 Added 1668.29%	725 $10,000
Q1 2021 May 13, 2021	BUY	$5.24 - $10.14 $214 - $415	41 New	41 $0
Q4 2019 Feb 10, 2020	SELL	$3.36 - $5.04 $221 - $332	-66 Closed	0 $0

Q3 2019 Nov 14, 2019	BUY	$4.89 - $7.18 $224 - $330	46 Added 230.0%	66 $0
Q2 2019 Aug 14, 2019	BUY	$4.93 - $7.2 $98 - $144	20 New	20 $0

61.6K

Ticker PLXP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,137,700
Description
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.